Skip to main content
. Author manuscript; available in PMC: 2015 Jul 27.
Published in final edited form as: J Proteome Res. 2009 Jun;8(6):2656–2666. doi: 10.1021/pr8008385

Figure 6.

Figure 6

MALDI mass spectra illustrating the difference in the intensity of N-glycans derived from human blood serum of (a, b) a disease-free subject (green trace) vs. patient with esophageal adenocarcinoma (red trace); (c) a disease free subject (green trace) vs. patient with HGD esophagus (pink trace) and (d) a patient with HGD esophagus (pink trace) vs. that with esophageal adenocarcinoma (red trace). Symbols: as in Figure 3